{
  "main_header": {
    "sid": 696114,
    "name": "Zydus Wellness",
    "stock_name": "Zydus Wellness",
    "full_name": "Zydus Wellness Ltd",
    "name_url": "stocks-analysis/zydus-wellness",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "407.10",
    "chg": -9.05,
    "chgp": "-2.17%",
    "dir": -1,
    "prev_price": "416.15",
    "mcapval": "13,103.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 531335,
    "symbol": "ZYDUSWELL",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE768C01028",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.4 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-wellness-696114-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Zydus Wellness Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-wellness-downgraded-to-sell-by-marketsmojo-amid-weak-financial-trends-3733206",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZydusWellness_mojoScore_3733206.png",
        "date": "2025-11-27 10:05:56",
        "description": "Zydus Wellness has experienced a revision in its market evaluation, reflecting a shift in analytical perspective driven by recent financial and technical developments. The company, operating within the FMCG sector as a small-cap entity, has shown a complex performance pattern that has influenced this reassessment."
      },
      {
        "title": "Why is Zydus Wellness falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-zydus-wellness-fallingrising-3732174",
        "imagepath": "",
        "date": "2025-11-27 00:42:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has underperformed notably in the short term, falling 4.52% over the past week while the Sensex gained 0.50%. Over the last month, the decline is more pronounced at 10.24%, contrasting with the Sensex’s 1.66% rise. Although the year-to-date and one-year returns remain positive at 12.04% and 12.86% respectively, these gains are modest compared to the broader market’s performance. The five-year return of 18.12% also lags significantly behind the Sensex’s 93.43% surge, indicating a longer-term underperformance relative to the benchmark.</p>\n<p>On the day in question, Zydus Wellness underperformed its sector by 2.04%, continuing a two-day losing streak that has resulted in a cumulative 2.61% decline. The stock’s price currently s..."
      },
      {
        "title": "Is Zydus Wellness overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-zydus-wellness-overvalued-or-undervalued-3677936",
        "imagepath": "",
        "date": "2025-11-07 08:09:25",
        "description": "As of 6 November 2025, the valuation grade for Zydus Wellness has moved from fair to expensive, indicating a shift in its market perception. The company is currently considered overvalued. Key ratios include a PE ratio of 49.20, an EV to EBITDA of 44.54, and a Price to Book Value of 0.25, which suggest that the stock is trading at a premium compared to its earnings and asset value.\n\nIn comparison to its peers, Zydus Wellness has a lower PE ratio than Hindustan Unilever, which stands at 54.11, and Nestle India, which has a PE of 81.85. However, the overall valuation of Zydus Wellness remains expensive in the context of the FMCG sector, where many peers are also categorized as very expensive. Despite a strong year-to-date return of 14.50% compared to the Sensex's 6.62%, the stock's recent performance has been lackluster, with a 1-week decline of 8.76%, reinforcing the notion that it may be overvalued at curre..."
      },
      {
        "title": "How has been the historical performance of Zydus Wellness?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-zydus-wellness-3677233",
        "imagepath": "",
        "date": "2025-11-06 22:58:17",
        "description": "Answer:\nThe historical performance of Zydus Wellness shows a consistent growth trajectory in net sales and profit over the years, with notable fluctuations in profit margins and cash flow.\n\nBreakdown:\nZydus Wellness has demonstrated significant growth in net sales, increasing from 1,766.82 Cr in March 2020 to 2,708.90 Cr in March 2025. The total operating income has mirrored this growth, reaching 2,708.90 Cr in March 2025, up from 1,766.82 Cr in March 2020. The operating profit (PBDIT) has also shown an upward trend, with a peak of 393.30 Cr in March 2025, although it experienced some fluctuations in previous years. Profit before tax reached 358.80 Cr in March 2025, while profit after tax stood at 346.90 Cr, indicating a healthy profitability despite a slight decline from the previous year. The company’s total liabilities increased to 6,297.20 Cr in March 2025, up from 5,468.89 Cr in March 2020, reflecting ..."
      },
      {
        "title": "Are Zydus Wellness latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zydus-wellness-latest-results-good-or-bad-3676442",
        "imagepath": "",
        "date": "2025-11-06 19:19:23",
        "description": "Zydus Wellness has reported its financial results for Q2 FY26, revealing significant challenges in its performance. The company recorded a net profit of -₹52.80 crores, marking a substantial decline compared to the previous quarter and the same quarter last year. This represents the first quarterly loss in recent history, raising concerns about the company's profitability and operational efficiency.\n\nRevenue for the quarter stood at ₹650.50 crores, which reflects a sequential decline of 24.44% from ₹860.90 crores in Q1 FY26. However, on a year-on-year basis, revenue showed growth of 31.97%, indicating some underlying demand strength. Despite this, the operating margin fell sharply to 3.58%, down from 18.14% in the previous quarter, highlighting severe operational stress. The company’s return on capital employed (ROCE) also hit a multi-year low of 3.34%, and return on equity (ROE) was recorded at 5.88%, both..."
      },
      {
        "title": "Zydus Wellness Faces Financial Challenges Amidst Strong Cash Flow and Dividend Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-wellnesss-financial-trend-shifts-from-positive-to-negative-amid-declining-profitability-3675646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZydusWellness_fintrenddot_3675646.png",
        "date": "2025-11-06 11:00:38",
        "description": "Zydus Wellness has faced challenges in its financial performance for the quarter ending September 2025, with a decline in profitability metrics. Despite this, the company reported strong operating cash flow and liquidity. Its stock has outperformed the Sensex over the past year, though it has lagged in longer-term comparisons."
      },
      {
        "title": "Zydus Wellness Q2 FY26: Sharp Loss Raises Red Flags Despite Strong H1 Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/zydus-wellness-q2-fy26-sharp-loss-raises-red-flags-despite-strong-h1-revenue-growth-3675862",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZydusWellness_quaterlyResult_3675862.png",
        "date": "2025-11-06 09:51:59",
        "description": "Zydus Wellness Ltd., the consumer wellness products company with brands like Complan, Nutralite, and Sugar Free, reported a jarring quarterly loss of ₹52.80 crores for Q2 FY26, marking a dramatic reversal from the ₹127.90 crores profit posted just one quarter earlier. The loss represents a staggering 352.63% decline year-on-year, sending shockwaves through investor circles and triggering a 2.81% decline in the stock price to ₹450.25 on November 6, 2025."
      },
      {
        "title": "Why is Zydus Wellness falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-zydus-wellness-fallingrising-3672148",
        "imagepath": "",
        "date": "2025-11-04 22:54:01",
        "description": "As of 04-Nov, Zydus Wellness Ltd is experiencing a decline in its stock price, currently at Rs 463.25, which reflects a decrease of Rs 15.9 or 3.32%. The stock has underperformed its sector by 3.1% today, touching an intraday low of Rs 457.15, indicating a significant drop of 4.59%. Over the past week, the stock has seen a decline of 6.37%, while its performance over the last month is nearly flat at -0.08%. Despite these short-term challenges, the stock has shown a year-to-date increase of 19.26% and a one-year return of 18.90%, which is notably higher than the market average. The company maintains a low debt-to-equity ratio and has reported positive operational cash flow and growth in profit before tax, suggesting a stable financial position. However, the stock is trading at a premium compared to its peers, which may be contributing to the current selling pressure.\n\nIn the broader market context, Zydus Wel..."
      },
      {
        "title": "Is Zydus Wellness technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-zydus-wellness-technically-bullish-or-bearish-3669138",
        "imagepath": "",
        "date": "2025-11-04 08:44:54",
        "description": "As of 3 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating bullish momentum. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, suggesting mixed signals across time frames. Bollinger Bands are bullish on both weekly and monthly charts, reinforcing the positive outlook. However, the KST shows a bullish weekly trend but is mildly bearish monthly, indicating some caution. Overall, while there are bullish indicators, the mixed signals suggest a cautious approach...."
      }
    ],
    "total": 166,
    "sid": "696114",
    "stock_news_url": "https://www.marketsmojo.com/news/zydus-wellness-696114"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
      "datetime": "02-Dec-2025",
      "details": "Disclosure under SEBI (PIT) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "14-Nov-2025",
      "details": "Transcript of the Earnings Conference call held on November 5 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2025",
      "details": "Newspaper advertisement regarding unaudited financial results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Wellness Ltd has declared <strong>60%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Wellness Ltd has announced <strong>2:10</strong> stock split, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zydus Wellness Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-27 10:05:56

Zydus Wellness has experienced a revision in its market evaluation, reflecting a shift in analytical perspective driven by recent financial and technical developments. The company, operating within the FMCG sector as a small-cap entity, has shown a complex performance pattern that has influenced this reassessment.

Read More

Why is Zydus Wellness falling/rising?

2025-11-27 00:42:43

Recent Price Movement and Market Context

The stock has underperformed notably in the short term, falling 4.52% over the past week while the Sensex gained 0.50%. Over the last month, the decline is more pronounced at 10.24%, contrasting with the Sensex’s 1.66% rise. Although the year-to-date and one-year returns remain positive at 12.04% and 12.86% respectively, these gains are modest compared to the broader market’s performance. The five-year return of 18.12% also lags significantly behind the Sensex’s 93.43% surge, indicating a longer-term underperformance relative to the benchmark.

On the day in question, Zydus Wellness underperformed its sector by 2.04%, continuing a two-day losing streak that has resulted in a cumulative 2.61% decline. The stock’s price currently s...

Read More

Is Zydus Wellness overvalued or undervalued?

2025-11-07 08:09:25

As of 6 November 2025, the valuation grade for Zydus Wellness has moved from fair to expensive, indicating a shift in its market perception. The company is currently considered overvalued. Key ratios include a PE ratio of 49.20, an EV to EBITDA of 44.54, and a Price to Book Value of 0.25, which suggest that the stock is trading at a premium compared to its earnings and asset value. In comparison to its peers, Zydus Wellness has a lower PE ratio than Hindustan Unilever, which stands at 54.11, and Nestle India, which has a PE of 81.85. However, the overall valuation of Zydus Wellness remains expensive in the context of the FMCG sector, where many peers are also categorized as very expensive. Despite a strong year-to-date return of 14.50% compared to the Sensex's 6.62%, the stock's recent performance has been lackluster, with a 1-week decline of 8.76%, reinforcing the notion that it may be overvalued at curre...

Read More

How has been the historical performance of Zydus Wellness?

2025-11-06 22:58:17

Answer: The historical performance of Zydus Wellness shows a consistent growth trajectory in net sales and profit over the years, with notable fluctuations in profit margins and cash flow. Breakdown: Zydus Wellness has demonstrated significant growth in net sales, increasing from 1,766.82 Cr in March 2020 to 2,708.90 Cr in March 2025. The total operating income has mirrored this growth, reaching 2,708.90 Cr in March 2025, up from 1,766.82 Cr in March 2020. The operating profit (PBDIT) has also shown an upward trend, with a peak of 393.30 Cr in March 2025, although it experienced some fluctuations in previous years. Profit before tax reached 358.80 Cr in March 2025, while profit after tax stood at 346.90 Cr, indicating a healthy profitability despite a slight decline from the previous year. The company’s total liabilities increased to 6,297.20 Cr in March 2025, up from 5,468.89 Cr in March 2020, reflecting ...

Read More

Are Zydus Wellness latest results good or bad?

2025-11-06 19:19:23

Zydus Wellness has reported its financial results for Q2 FY26, revealing significant challenges in its performance. The company recorded a net profit of -₹52.80 crores, marking a substantial decline compared to the previous quarter and the same quarter last year. This represents the first quarterly loss in recent history, raising concerns about the company's profitability and operational efficiency. Revenue for the quarter stood at ₹650.50 crores, which reflects a sequential decline of 24.44% from ₹860.90 crores in Q1 FY26. However, on a year-on-year basis, revenue showed growth of 31.97%, indicating some underlying demand strength. Despite this, the operating margin fell sharply to 3.58%, down from 18.14% in the previous quarter, highlighting severe operational stress. The company’s return on capital employed (ROCE) also hit a multi-year low of 3.34%, and return on equity (ROE) was recorded at 5.88%, both...

Read More

Zydus Wellness Faces Financial Challenges Amidst Strong Cash Flow and Dividend Performance

2025-11-06 11:00:38

Zydus Wellness has faced challenges in its financial performance for the quarter ending September 2025, with a decline in profitability metrics. Despite this, the company reported strong operating cash flow and liquidity. Its stock has outperformed the Sensex over the past year, though it has lagged in longer-term comparisons.

Read More

Zydus Wellness Q2 FY26: Sharp Loss Raises Red Flags Despite Strong H1 Revenue Growth

2025-11-06 09:51:59

Zydus Wellness Ltd., the consumer wellness products company with brands like Complan, Nutralite, and Sugar Free, reported a jarring quarterly loss of ₹52.80 crores for Q2 FY26, marking a dramatic reversal from the ₹127.90 crores profit posted just one quarter earlier. The loss represents a staggering 352.63% decline year-on-year, sending shockwaves through investor circles and triggering a 2.81% decline in the stock price to ₹450.25 on November 6, 2025.

Read More

Why is Zydus Wellness falling/rising?

2025-11-04 22:54:01

As of 04-Nov, Zydus Wellness Ltd is experiencing a decline in its stock price, currently at Rs 463.25, which reflects a decrease of Rs 15.9 or 3.32%. The stock has underperformed its sector by 3.1% today, touching an intraday low of Rs 457.15, indicating a significant drop of 4.59%. Over the past week, the stock has seen a decline of 6.37%, while its performance over the last month is nearly flat at -0.08%. Despite these short-term challenges, the stock has shown a year-to-date increase of 19.26% and a one-year return of 18.90%, which is notably higher than the market average. The company maintains a low debt-to-equity ratio and has reported positive operational cash flow and growth in profit before tax, suggesting a stable financial position. However, the stock is trading at a premium compared to its peers, which may be contributing to the current selling pressure. In the broader market context, Zydus Wel...

Read More

Is Zydus Wellness technically bullish or bearish?

2025-11-04 08:44:54

As of 3 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating bullish momentum. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, suggesting mixed signals across time frames. Bollinger Bands are bullish on both weekly and monthly charts, reinforcing the positive outlook. However, the KST shows a bullish weekly trend but is mildly bearish monthly, indicating some caution. Overall, while there are bullish indicators, the mixed signals suggest a cautious approach....

Read More

View All News